{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T14:15:14Z","timestamp":1747232114927,"version":"3.40.5"},"reference-count":0,"publisher":"Tunisian Society of Medical Sciences","issue":"3","license":[{"start":{"date-parts":[[2024,3,10]],"date-time":"2024-03-10T00:00:00Z","timestamp":1710028800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tunis Med"],"abstract":"<jats:p>Introduction : Malgr\u00e9 l'efficacit\u00e9 des mesures de pr\u00e9vention cardiovasculaire (CV), le contr\u00f4le des facteurs de risque (FR) CV reste insuffisant chez les patients \u00e0 tr\u00e8s haut risque.\nObjectif : Evaluer la pr\u00e9valence de l'atteinte des cibles th\u00e9rapeutiques recommand\u00e9es pour les FRCV majeurs et modifiables 12 mois apr\u00e8s un infarctus du myocarde (IDM).\nM\u00e9thodes : Du 1er janvier au 30 avril 2023, nous avons collig\u00e9 des patients cons\u00e9cutifs ayant eu un IDM de type 1 et ayant totalis\u00e9 12 mois de suivi. Le crit\u00e8re de jugement primaire (CJP) \u00e9tait le taux d\u2019atteinte de toutes les cibles th\u00e9rapeutiques recommand\u00e9es pour le diab\u00e8te, l\u2019hypertension art\u00e9rielle (HTA), le LDL-C et le tabagisme. Les cibles th\u00e9rapeutiques ont \u00e9t\u00e9 d\u00e9finies conform\u00e9ment aux recommandations de la Soci\u00e9t\u00e9 Europ\u00e9enne de Cardiologie de 2021.\nR\u00e9sultats : 107 patients, d'\u00e2ge moyen 58,8\u00b18,8 ans, 74,8% de sexe masculin, ont \u00e9t\u00e9 inclus. 42 (39,3%) avaient une HTA, 50 (46,7%) \u00e9taient diab\u00e9tiques, 77 (72,0%) \u00e9taient fumeurs et huit (7,5%) avaient une hypercholest\u00e9rol\u00e9mie. \u00c0 12 mois, le CJP \u00e9tait atteint chez 20 (18,7%) patients. 55 (71,4%) des 77 patients fumeurs \u00e9taient sevr\u00e9s. La pression art\u00e9rielle \u00e9tait \u00e0 la cible chez 26 (61,9%) patients parmi les hypertendus. Chez les patients diab\u00e9tiques, l'objectif d'HbA1c \u00e9tait atteint chez 23 (46,0%) d'entre eux. 32 patients (29,9%) ont atteint l'objectif de LDL-C &lt;0,55 g\/l.\nConclusions : La pr\u00e9vention secondaire des maladies CV \u00e9tait suboptimale. Moins du cinqui\u00e8me des patients ont atteint l'objectif th\u00e9rapeutique pour les FRCV modifiables. Il est n\u00e9cessaire d'am\u00e9liorer la prise en charge apr\u00e8s IDM.<\/jats:p>","DOI":"10.62438\/tunismed.v102i3.4713","type":"journal-article","created":{"date-parts":[[2024,3,10]],"date-time":"2024-03-10T12:17:58Z","timestamp":1710073078000},"source":"Crossref","is-referenced-by-count":0,"title":["Atteinte des cibles th\u00e9rapeutiques recommand\u00e9es en pr\u00e9vention secondaire apr\u00e8s infarctus du myocarde dans un centre tertiaire nord-africain"],"prefix":"10.62438","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1627-5426","authenticated-orcid":false,"given":"Faten","family":"El Ayech Boudiche","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selim","family":"Boudiche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Safia","family":"Othmani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajer","family":"Mehri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed Omar","family":"Yaakoub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malek","family":"Larbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leila","family":"Bezdah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"31112","published-online":{"date-parts":[[2024,3,10]]},"container-title":["La Tunisie M\u00e9dicale"],"original-title":[],"deposited":{"date-parts":[[2024,3,10]],"date-time":"2024-03-10T12:17:59Z","timestamp":1710073079000},"score":1,"resource":{"primary":{"URL":"https:\/\/latunisiemedicale.com\/index.php\/tunismed\/article\/view\/4713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,10]]},"references-count":0,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,3,10]]}},"URL":"https:\/\/doi.org\/10.62438\/tunismed.v102i3.4713","relation":{},"ISSN":["2724-7031","0041-4131"],"issn-type":[{"type":"electronic","value":"2724-7031"},{"type":"print","value":"0041-4131"}],"subject":[],"published":{"date-parts":[[2024,3,10]]}}}